Cancer Research UK logo.
SearchDonate
  • Search

A trial of enadenotucirev for ovarian cancer (OCTAVE)

Overview

Cancer types:

Ovarian cancer

Status:

Results

Phase:

Phase 1

Details

This trial was for women with ovarian cancer that had got worse after having

It was for women who had 1 of the following:

  • ovarian cancer

  • primary peritoneal cancer

  • fallopian tube cancer

Doctors treat these cancers in the same way. When we use the term ovarian cancer in this summary we are referring to all of these.

This trial was open for women to join between 2014 and 2018. The team published the results in 2021.

Recruitment start: 2 June 2014

Recruitment end: 17 December 2018

How to join

Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Iain McNeish

Supported by

Akamis Bio Ltd

NIHR Clinical Research Network: Cancer

Last reviewed: 23 Apr 2023

CRUK internal database number: 11596

Help and support